These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27684817)

  • 21. Fibrinogen Poissy II (gammaN361K): a novel dysfibrinogenemia associated with defective polymerization and peptide B release.
    Mathonnet F; Guillon L; Detruit H; Mazmanian GM; Dreyfus M; Alvarez JC; Giudicelli Y; de Mazancourt P
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):293-8. PubMed ID: 12695754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis of congenital fibrinogen disorders.
    Lebreton A; Casini A
    Ann Biol Clin (Paris); 2016 Aug; 74(4):405-12. PubMed ID: 27492693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrinogen Milano IV, another case of congenital dysfibrinogenemia with an abnormal fibrinopeptide A release (A alpha 16 Arg----His).
    Bögli C; Hofer A; Baudo F; Redaelli R; Furlan M
    Haemostasis; 1992; 22(1):7-11. PubMed ID: 1521828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrinogen Barcelona I. Congenital dysfibrinogenemia characterized by defective release of fibrinopeptide A and fibrinogen degradation products.
    Vila V; Regañón E; Aznar J; Navarro G; Salas M
    Thromb Res; 1987 Mar; 45(5):437-49. PubMed ID: 2954261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analysis of a family with congenital dysfibrinogenemia caused by an Arg275His mutation in the gamma chain of fibrinogen].
    Yan J; Deng D; Deng X; Luo M; Cheng P; Liao L; Lin F
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Apr; 33(2):160-3. PubMed ID: 27060305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coexisting congenital dysfibrinogenemia with a novel mutation in fibrinogen γ chain (γ322 Phe→Ile, Fibrinogen Beijing) and haemophilia B in a family.
    Hua B; Li K; Lee A; Poon MC; Zhao Y
    Haemophilia; 2015 Nov; 21(6):846-51. PubMed ID: 25982359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Congenital afibrinogenemia: Identification and characterization of two novel homozygous fibrinogen Aα and Bβ chain mutations in two Tunisian families.
    Amri Y; Toumi Nel H; Hadj Fredj S; de Moerloose P
    Thromb Res; 2016 Jul; 143():11-6. PubMed ID: 27164460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two cases of congenital dysfibrinogenemia associated with thrombosis - Fibrinogen Praha III and Fibrinogen Plzen.
    Kotlín R; Reicheltová Z; Malý M; Suttnar J; Sobotková A; Salaj P; Hirmerová J; Riedel T; Dyr JE
    Thromb Haemost; 2009 Sep; 102(3):479-86. PubMed ID: 19718467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two novel fibrinogen variants in the C-terminus of the Bβ-chain: fibrinogen Rokycany and fibrinogen Znojmo.
    Kotlín R; Reicheltová Z; Suttnar J; Salaj P; Hrachovinová I; Riedel T; Malý M; Oravec M; Kvasnicka J; Dyr JE
    J Thromb Thrombolysis; 2010 Oct; 30(3):311-8. PubMed ID: 20640913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two cases of dysfibrinogenemia characterized by abnormal FPB release: fibrinogen Madrid I & II.
    Borrell M; Vila L; Solá J; Coll I; Gómez N; González N; Rutllant ML
    Thromb Res; 1987 Mar; 45(5):591-9. PubMed ID: 3109061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel heterozygous mutation (γIIe367Thr) causes congenital dysfibrinogenemia in a Chinese family.
    Luo S; Xu Q; Xie Y; Li X; Jin Y; Yang L; Liu S; Wang M
    Blood Coagul Fibrinolysis; 2020 Dec; 31(8):569-574. PubMed ID: 32833807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Congenital hypodysfibrinogenemia associated with a novel deletion of three residues (γAla289_Asp291del) in fibrinogen.
    Zhu L; Zhao M; Wang M; Lou Z; Chen X; Pan L; Yu D; Xia W; Wang H; Zhou B; Gao S
    J Thromb Thrombolysis; 2018 Aug; 46(2):211-218. PubMed ID: 29748775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibrinogen Caracas V, an abnormal fibrinogen with an Aalpha 532 Ser-->Cys substitution associated with thrombosis.
    Marchi R; Lundberg U; Grimbergen J; Koopman J; Torres A; de Bosch NB; Haverkate F; Arocha Piñango CL
    Thromb Haemost; 2000 Aug; 84(2):263-70. PubMed ID: 10959699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterozygous variant fibrinogen γA289V (Kanazawa III) was confirmed as hypodysfibrinogenemia by plasma and recombinant fibrinogens.
    Kaido T; Yoda M; Kamijo T; Taira C; Higuchi Y; Okumura N
    Int J Lab Hematol; 2020 Apr; 42(2):190-197. PubMed ID: 31957968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Congenital dysfibrinogenemia in major surgery: A description of four cases and review of the literature.
    Yan J; Luo M; Xiang L; Wu Y; Lin F
    Clin Chim Acta; 2022 Mar; 528():1-5. PubMed ID: 35063457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Inherited dysfibrinogenemia caused by Arg16His mutation in alpha chain of fibrinogen.].
    Zhao XJ; Wang ZY; Jiang MH; Zhang W; Cao LJ; Ma ZN; Dong NZ; Bai X; Yu ZQ; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2010 Mar; 31(3):154-6. PubMed ID: 20510102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of dysfibrinogenemia without hemorrhagic diathesis or thromboembolism linked to a new mutation p.H103N in fibrinogen γ chain].
    Devignes J; Hanss M; Chabaud A; Toussaint-Hacquard M; Mansuy L; De Mazancourt P; Lecompte T
    Ann Biol Clin (Paris); 2013; 71(4):489-95. PubMed ID: 23906582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrinogen Guarenas I: partial characterization of a new dysfibrinogenemia with an altered rate of fibrinopeptide release and an impaired polymerization.
    Lundberg UG; Rodriguez S; Marchi R; Ruiz-Saez A; Arocha-Piñango CL
    Thromb Res; 1995 Apr; 78(2):95-106. PubMed ID: 7482436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a novel splicing mutation in the fibrinogen gamma chain gene leading to dysfibrinogenaemia in a Chinese pedigree.
    Huang D; Chen H; Hu X; Wang X; Wang H
    Pathology; 2015 Feb; 47(2):145-50. PubMed ID: 25551304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrinogen Alès: a homozygous case of dysfibrinogenemia (gamma-Asp(330)-->Val) characterized by a defective fibrin polymerization site "a".
    Lounes KC; Soria C; Mirshahi SS; Desvignes P; Mirshahi M; Bertrand O; Bonnet P; Koopman J; Soria J
    Blood; 2000 Nov; 96(10):3473-9. PubMed ID: 11071644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.